Search…

    Saved articles

    You have not yet added any article to your bookmarks!

    Browse articles

    GDPR Compliance

    We use cookies to ensure you get the best experience on our website. By continuing to use our site, you accept our use of cookies, Privacy Policies, and Terms of Service.

    FDA Approves Journavx Drug to Treat Pain Without Addiction Risk

    2 months ago

    13

    0

    The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive.
    Click here to Read more
    Prev Article
    Doug Burgum Is Confirmed by Senate as Interior Secretary
    Next Article
    RFK Jr. Says He Won’t Keep Financial Stake in HPV Vaccine Lawsuits

    Related Science and Technology Updates:

    Comments (0)

      Leave a Comment